Edward F Patz

8PUBLICATIONS
39CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 18, 2026
KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma.

|Apr 28, 2026
Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.

|Feb 26, 2025
A tumor-binding antibody with cross-reactivity to viral antigens.

Michael J Campa, Elizabeth B Gottlin, Kevin Wiehe

|Jan 03, 2025
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

Jeffrey M Clarke, George R Simon, Hirva Mamdani

|Apr 01, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody.

Ruchi Saxena, Ryan T Bushey, Michael J Campa

|Mar 30, 2023
Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.

Ryan T Bushey, Ruchi Saxena, Michael J Campa

Pageof 2

Frequent Collaborators

4 joint publications

Michael J Campa

4 joint publications

Elizabeth B Gottlin

3 joint publications

Ryan T Bushey

3 joint publications

Ruchi Saxena